Transcat, Inc.

TRNS • Industrial - Distribution

$85.48

▼ -0.21 (-0.25%)

Current price

EarningsLatest report: Jun 27, 2026

BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.

Market Cap

$809.75M

Growth

6.1%

Cash Flow

5/5

Trend

Stable

Evidence

Positive free cash flow · 2.09Consistent free cash flow · 5/5Manageable debt level · 0.43Healthy liquidity · 2.33Expensive earnings multiple · 122.97

Financial data as of: Jun 27, 2026, 12:00 AM UTCLast earnings update: Jun 27, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:06 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$85.48

Change-0.25%

Shares Out9.47M

Market Cap$809.75M

Enterprise Value$913.43M

52W Range50.23 - 95.22

Beta0.68

P/E90.83

P/S2.35

P/B2.67

P/FCF41.53

EV/Sales2.65

Price$85.48

Change-0.25%

Shares Out9.47M

Market Cap$809.75M

Enterprise Value$913.43M

52W Range50.23 - 95.22

Beta0.68

P/E90.83

P/S2.35

P/B2.67

P/FCF41.53

EV/Sales2.65

EV/EBITDA25.42

EV/FCF46.84

Earnings Yield1.10%

FCF Yield2.41%

Dividend Yield0.00%

Gross Margin32.63%

Oper. Margin4.00%

Profit Margin1.62%

Debt/Eq0.43

Current Ratio2.33

Quick Ratio1.99

Revenue 5Y6.11%

Target$123.60

Target Upside44.60%

Target Median$113.00

Target Range94.00 - 160.00

Volume348.88K

Avg Volume161.19K

EPS Surprise0.05

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

27/100

Financial Strength

Debt, cash, stability

76/100

Growth Potential

Revenue and expansion

77/100

Price Attractiveness

Cheap or expensive today

57/100

Why this score▼

Positive free cash flow · 2.09Consistent free cash flow · 5/5Manageable debt level · 0.43Healthy liquidity · 2.33Expensive earnings multiple · 122.97Weak profitability

Analyst view

Analyst sentiment and price target

TRNS

Analyst sentiment

Based on 10 analyst votes · 2026-09-05

90/100

Bullish

Hold

Bearish

Price Target

2026-08-06

Low

$94.00

Mean

$123.60

Median

$113.00

High

$160.00

Company Overview

IPO: 12/5/1977

Industry: Industrial - Distribution

P/B i: 2.67

Debt / Equity i: 0.43

Operating Margin: 4.00%

Net Margin: 1.62%

ROE i: -

ROIC: -

Financial Health

Score15 / 20

Debt / Equity: 0.43

Current Ratio: 2.33

Quick Ratio: 1.99

Status: Good

Insider Transactions

Recent executive and insider activity

Simmons Royal Thomas Jr.

Transaction: 06/22/2026

OTHER

Change

Price

Not reported

Filing

06/24/2026

Type

OTHER

Simmons Royal Thomas Jr.

Transaction: 06/22/2026

BUY

Change

+1,508

Price

Not reported

Filing

06/24/2026

Type

BUY

Rudow Lee D.

Transaction: 03/28/2026

SELL

Change

-3,785

Price

Not reported

Filing

06/11/2026

Type

SELL

Insider	Type	Change	Price	Transaction	Filing
Simmons Royal Thomas Jr.	OTHER	0	Not reported	06/22/2026	06/24/2026
Simmons Royal Thomas Jr.	BUY	+1,508	Not reported	06/22/2026	06/24/2026
Rudow Lee D.	SELL	-3,785	Not reported	03/28/2026	06/11/2026
Rudow Lee D.	BUY	+3,785	Not reported	03/28/2026	06/11/2026
Rudow Lee D.	SELL	-5,000	Not reported	03/26/2026	06/11/2026
Rudow Lee D.	SELL	-1,867	$72.97	03/26/2026	06/11/2026
IRICK JAIME A	BUY	+15,043	Not reported	05/27/2026	05/28/2026
Barbato Thomas L	BUY	+3,925	Not reported	05/27/2026	05/28/2026
Barbato Thomas L	SELL	-760	$76.45	05/27/2026	05/28/2026
Conroy Theresa A.	BUY	+1,382	Not reported	05/27/2026	05/28/2026
Conroy Theresa A.	SELL	-335	$76.45	05/27/2026	05/28/2026
Haddad Michael Jacques	BUY	+1,382	Not reported	05/27/2026	05/28/2026
West Michael W.	BUY	+1,807	Not reported	05/27/2026	05/28/2026
West Michael W.	SELL	-465	$76.45	05/27/2026	05/28/2026
Johnston Kristina L	BUY	+409	Not reported	05/27/2026	05/28/2026
IRICK JAIME A	OTHER	0	Not reported	03/29/2026	04/02/2026
Conroy Theresa A.	SELL	-524	Not reported	03/28/2026	04/01/2026
Conroy Theresa A.	SELL	-232	$71.32	03/28/2026	04/01/2026
Barbato Thomas L	SELL	-1,186	Not reported	03/28/2026	04/01/2026
Barbato Thomas L	SELL	-524	$71.32	03/28/2026	04/01/2026

About the Company

Transcat, Inc.

Transcat, Inc. offers comprehensive calibration and instrument services for laboratories, serving clients across the United States, Canada, and other international markets. The company operates through two distinct divisions: Service and Distribution. The Service division delivers a wide array of offerings, including precision calibration, equipment repair, thorough inspections, analytical qualification, preventive maintenance, and expert consulting. This segment also features its proprietary software, CalTrak, designed to manage documents and assets while streamlining the operational workflow for its calibration centers and customer equipment. Additionally, its "Compliance, Control and Cost" online portal grants customers web-based asset management capabilities and a secure, off-site repository for calibration and other service records. The Distribution division focuses on the sale and rental of instruments for testing, measurement, and control purposes. It also provides valuable supplementary services such as the calibration and certification of newly purchased equipment, equipment leasing, sales of pre-owned machinery, and customized equipment kitting. This division engages customers through its online platform, various digital and print marketing campaigns, proactive outbound sales efforts, and an incoming call center. Transcat primarily caters to highly regulated sectors, particularly the life sciences—encompassing pharmaceutical, biotechnology, medical device, and other FDA-regulated entities. Furthermore, it extends its services and products to aerospace and defense, industrial manufacturing, energy, utilities, and other industries where process accuracy and confirmed equipment performance are paramount. Established in 1964, Transcat, Inc. maintains its corporate headquarters in Rochester, New York.

Source - link

Peers

FIP GHM GNK HY KE KRNT NX RGR RR SNCY

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical.

Business Wire

Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September.

Business Wire

Dimensional Fund Advisors LP Grows Position in Transcat, Inc. $TRNS

Dimensional Fund Advisors LP grew its position in Transcat, Inc. (NASDAQ: TRNS) by 3.7% during the quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 262,033 shares of the scientific and technical instruments company's stock after purchasing an additional 9,266 shares during the

Defense World

Transcat, Inc. (TRNS) Q1 2027 Earnings Call Transcript

Seeking Alpha

Transcat Q1 Earnings Call Highlights

Transcat NASDAQ: TRNS reported first-quarter fiscal 2027 revenue of $92.9 million, up 22% from a year earlier, as both its calibration services and distribution segments posted double-digit growth. The company said demand remained strong across its regulated end markets, including life sciences, aerospace and defense, and energy.

MarketBeat

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-05-26	0.51	0.56	0.05
2026-02-03	0.3	0.26	-0.04
2025-11-03	0.46	0.44	-0.02
2025-08-06	0.4	0.59	0.19
2025-05-19	0.66	0.64	-0.02
2025-01-27	0.38	0.45	0.07
2024-10-28	0.47	0.35	-0.12
2024-07-29	0.29	0.48	0.19
2024-05-20	0.52	0.77	0.25
2024-01-30	0.35	0.38	0.03
2023-10-31	0.37	0.41	0.04
2023-08-01	0.27	0.38	0.11